Cargando…
Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models
Myeloproliferative neoplasms (MPNs) are characterized by the activated JAK2/STAT pathway. Pleckstrin-2 (Plek2) is a downstream target of the JAK2/STAT5 pathway and is overexpressed in patients with MPNs. We previously revealed that Plek2 plays critical roles in the pathogenesis of JAK2-mutated MPNs....
Autores principales: | Han, Xu, Mei, Yang, Mishra, Rama K., Bi, Honghao, Jain, Atul D., Schiltz, Gary E., Zhao, Baobing, Sukhanova, Madina, Wang, Pan, Grigorescu, Arabela A., Weber, Patricia C., Piwinski, John J., Prado, Miguel A., Paulo, Joao A., Stephens, Len, Anderson, Karen E., Abrams, Charles S., Yang, Jing, Ji, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014099/ https://www.ncbi.nlm.nih.gov/pubmed/36719747 http://dx.doi.org/10.1172/JCI159638 |
Ejemplares similares
-
Emerging Roles of Pleckstrin-2 Beyond Cell Spreading
por: Wang, Gengchen, et al.
Publicado: (2021) -
Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019) -
Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018) -
Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
por: Gao, Juehua, et al.
Publicado: (2021) -
Ph-Negative Chronic Myeloproliferative Neoplasm (Primary Myelofibrosis) – as One of the Reasons of the Budd-Chiari Syndrome
por: Sokolova, M., et al.
Publicado: (2012)